TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
TSHA

Taysha Gene Therapies Inc

Healthcare · Biotechnology · —

4.60$ -2.3% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow TSHA
Line item 2019 2020 2021 2022 2023 2024 2025
– -22,862.2% – – – – –
– +0.0% +5,366.7% +138.2% +17.0% -9.2% -8.0%
– – +442.2% -0.8% -56.2% +65.8% +1.5%
– +649.6% -3.6% +104.6% – – –
– -120.6% – -35.4% -197.3% – –
– +10,975.6% +137.3% +15.4% -70.4% -94.9% +97.3%
– +0.0% +137.3% +15.7% -70.5% -95.1% +66.4%
– – – – – – –
– +0.0% +0.0% -100.0% – -100.0% –
– +0.0% -86.6% +33.3% +161.8% -43.8% +258.1%
– +186,013.3% -139.6% – – -108.8% –
– -29,589.6% – – – – –

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?